logo

IBRX

ImmunityBio·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
4.72 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy IBRX Now?
  • Based on a composite score of 4.72/10, we rate IBRX as a Netural. Our analysis breaks down into 2.23/10 for Fundamentals, 3.96/10 for Technicals, and 6.35/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is IBRX fundamentally strong?
What is the current technical signals for IBRX?
What is the market sentiment for IBRX?